First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.7 USD 5.9%
Updated: Mar 28, 2024

Relative Value

The Relative Value of one ATRA stock under the Base Case scenario is 14.33 USD. Compared to the current market price of 0.7 USD, Atara Biotherapeutics Inc is Undervalued by 95%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATRA Relative Value
Base Case
14.33 USD
Undervaluation 95%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
34
vs Industry
39
Median 3Y
18.7
Median 5Y
5.1
Industry
8.2
Forward
4.5
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.5
Industry
26
Forward
-0.3
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-3.2
Industry
21.5
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-3.1
Industry
24.3
vs History
vs Industry
70
Median 3Y
3
Median 5Y
2.9
Industry
2.7
vs History
vs Industry
74
Median 3Y
4
Median 5Y
-1.1
Industry
7.4
Forward
-2
vs History
6
vs Industry
22
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
6
vs Industry
27
Median 3Y
-0.6
Median 5Y
-1.6
Industry
4.2
Forward
0.1
vs History
6
vs Industry
25
Median 3Y
-0.5
Median 5Y
-1.6
Industry
4.3
Forward
0.1
vs History
6
vs Industry
27
Median 3Y
-0.6
Median 5Y
-2
Industry
5.3
vs History
6
vs Industry
24
Median 3Y
-0.6
Median 5Y
-1.9
Industry
3.3
vs History
vs Industry
72
Median 3Y
1.8
Median 5Y
5.9
Industry
5

Multiples Across Competitors

ATRA Competitors Multiples
Atara Biotherapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Atara Biotherapeutics Inc
NASDAQ:ATRA
71.3m USD 15.7 -0.2 0.1 0.1
US
Abbvie Inc
NYSE:ABBV
318.5B USD 5.9 66.1 14.2 21.6
US
Amgen Inc
NASDAQ:AMGN
153.3B USD 5.4 22.8 16.8 25.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
107.5B USD 10.9 29.7 23.9 25
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.7B USD 8.1 26.7 18.1 19.9
US
Gilead Sciences Inc
NASDAQ:GILD
91B USD 3.4 16.1 9.6 12.8
AU
CSL Ltd
ASX:CSL
138.3B AUD 6.4 36.8 22.1 27.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.2B USD 6.2 -9 -9.5 -8.1
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 27 14.6 18.1
KR
Celltrion Inc
KRX:068270
40.2T KRW 17.4 66.4 41.9 55

See Also

Discover More